Orbimed Advisors as of June 30, 2022
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 139 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sinovac Biotech SHS | 6.3 | $350M | 2.7M | 128.55 | |
| Bristol Myers Squibb (BMY) | 3.5 | $194M | 2.5M | 77.00 | |
| Humana (HUM) | 3.1 | $171M | 366k | 468.07 | |
| Horizon Therapeutics Pub L SHS | 3.0 | $168M | 2.1M | 79.76 | |
| Boston Scientific Corporation (BSX) | 3.0 | $163M | 4.4M | 37.27 | |
| Turning Point Therapeutics I | 2.7 | $151M | 2.0M | 75.25 | |
| Springworks Therapeutics (SWTX) | 2.7 | $148M | 6.0M | 24.62 | |
| UnitedHealth (UNH) | 2.6 | $144M | 281k | 513.63 | |
| Pfizer (PFE) | 2.6 | $144M | 2.7M | 52.43 | |
| BioMarin Pharmaceutical (BMRN) | 2.6 | $141M | 1.7M | 82.87 | |
| Seagen | 2.4 | $131M | 738k | 176.94 | |
| Abbvie (ABBV) | 2.2 | $123M | 800k | 153.16 | |
| Edgewise Therapeutics (EWTX) | 2.0 | $112M | 14M | 7.96 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.0 | $109M | 387k | 281.79 | |
| Adicet Bio (ACET) | 2.0 | $109M | 7.4M | 14.60 | |
| Sierra Oncology Com New | 2.0 | $108M | 2.0M | 54.99 | |
| Biohaven Pharmaceutical Holding | 1.9 | $105M | 719k | 145.71 | |
| Intuitive Surgical Com New (ISRG) | 1.9 | $104M | 517k | 200.71 | |
| Arcutis Biotherapeutics (ARQT) | 1.8 | $102M | 4.8M | 21.31 | |
| Tricida | 1.8 | $100M | 10M | 9.68 | |
| Edwards Lifesciences (EW) | 1.7 | $96M | 1.0M | 95.09 | |
| Theseus Pharmaceuticals | 1.7 | $94M | 17M | 5.53 | |
| Pmv Pharmaceuticals (PMVP) | 1.7 | $94M | 6.6M | 14.25 | |
| Stryker Corporation (SYK) | 1.6 | $88M | 441k | 198.93 | |
| Neurocrine Biosciences (NBIX) | 1.5 | $83M | 850k | 97.48 | |
| Argenx Se Sponsored Adr (ARGX) | 1.3 | $74M | 194k | 378.88 | |
| Mirati Therapeutics | 1.3 | $73M | 1.1M | 67.13 | |
| Global Blood Therapeutics In | 1.2 | $65M | 2.0M | 31.95 | |
| Natera Call Option (NTRA) | 1.2 | $64M | 1.8M | 35.44 | |
| Thermo Fisher Scientific (TMO) | 1.1 | $62M | 113k | 543.28 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.1 | $60M | 3.2M | 18.65 | |
| Compass Therapeutics (CMPX) | 1.1 | $58M | 22M | 2.65 | |
| Evolent Health Cl A (EVH) | 1.0 | $55M | 1.8M | 30.71 | |
| Ikena Oncology Nonvoting | 1.0 | $54M | 12M | 4.43 | |
| Prelude Therapeutics (PRLD) | 1.0 | $52M | 10M | 5.22 | |
| Kinnate Biopharma | 0.9 | $51M | 4.0M | 12.61 | |
| Abcellera Biologics (ABCL) | 0.9 | $47M | 4.4M | 10.65 | |
| Repare Therapeutics Ord (RPTX) | 0.8 | $47M | 3.3M | 13.99 | |
| Keros Therapeutics (KROS) | 0.8 | $46M | 1.7M | 27.63 | |
| Syndax Pharmaceuticals (SNDX) | 0.8 | $45M | 2.3M | 19.24 | |
| Si-bone (SIBN) | 0.8 | $45M | 3.4M | 13.20 | |
| Guardant Health Call Option (GH) | 0.8 | $44M | 1.1M | 40.34 | |
| Gracell Biotechnologies Sponsored Ads | 0.8 | $43M | 7.9M | 5.50 | |
| Mersana Therapeutics | 0.8 | $42M | 9.0M | 4.62 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $40M | 1.3M | 30.42 | |
| Xtant Med Hldgs Com New (XTNT) | 0.7 | $38M | 73M | 0.52 | |
| Silverback Therapeutics (SPRY) | 0.7 | $37M | 8.7M | 4.24 | |
| Vectivbio Hldg Ord Shs | 0.6 | $35M | 6.5M | 5.40 | |
| Alpine Immune Sciences | 0.6 | $35M | 4.1M | 8.51 | |
| Janux Therapeutics (JANX) | 0.6 | $35M | 2.8M | 12.21 | |
| Tenet Healthcare Corp Com New (THC) | 0.6 | $35M | 656k | 52.56 | |
| Chinook Therapeutics | 0.6 | $33M | 1.9M | 17.49 | |
| Vaxcyte (PCVX) | 0.6 | $33M | 1.5M | 21.76 | |
| Aclaris Therapeutics (ACRS) | 0.6 | $33M | 2.3M | 13.96 | |
| Iovance Biotherapeutics (IOVA) | 0.6 | $31M | 2.8M | 11.04 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.4 | $24M | 5.7M | 4.19 | |
| Scpharmaceuticals (SCPH) | 0.4 | $23M | 4.8M | 4.82 | |
| Biogen Idec (BIIB) | 0.4 | $23M | 112k | 203.94 | |
| Tela Bio (TELA) | 0.4 | $21M | 3.0M | 7.01 | |
| Passage Bio | 0.4 | $21M | 8.9M | 2.36 | |
| Decibel Therapeutics | 0.4 | $21M | 4.9M | 4.21 | |
| Neuropace (NPCE) | 0.4 | $20M | 4.0M | 4.95 | |
| Rxsight (RXST) | 0.4 | $20M | 1.4M | 14.08 | |
| Meiragtx Holdings (MGTX) | 0.3 | $19M | 2.5M | 7.57 | |
| Travere Therapeutics (TVTX) | 0.3 | $19M | 772k | 24.23 | |
| Progyny (PGNY) | 0.3 | $18M | 625k | 29.05 | |
| Gilead Sciences (GILD) | 0.3 | $18M | 288k | 61.81 | |
| Alx Oncology Hldgs (ALXO) | 0.3 | $18M | 2.2M | 8.09 | |
| Ionis Pharmaceuticals (IONS) | 0.3 | $17M | 453k | 37.02 | |
| Adagio Therapeutics (IVVD) | 0.3 | $17M | 5.1M | 3.28 | |
| Uniqure Nv SHS (QURE) | 0.3 | $16M | 875k | 18.64 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $16M | 1.6M | 9.98 | |
| Rapt Therapeutics | 0.3 | $16M | 866k | 18.25 | |
| Ventyx Biosciences (VTYX) | 0.3 | $16M | 1.3M | 12.23 | |
| Amgen (AMGN) | 0.3 | $14M | 57k | 243.29 | |
| Bellus Health Com New | 0.2 | $13M | 1.5M | 9.20 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $13M | 22k | 591.13 | |
| Iveric Bio | 0.2 | $13M | 1.4M | 9.62 | |
| Ikena Oncology (IKNA) | 0.2 | $13M | 2.9M | 4.43 | |
| Nextcure (NXTC) | 0.2 | $13M | 2.7M | 4.70 | |
| Signify Health Cl A Com | 0.2 | $12M | 900k | 13.80 | |
| Theravance Biopharma (TBPH) | 0.2 | $12M | 1.4M | 9.06 | |
| Bridgebio Pharma Note 2.250% 2/0 (Principal) | 0.2 | $12M | 30M | 0.41 | |
| Vistagen Therapeutics Com New | 0.2 | $12M | 13M | 0.88 | |
| 89bio (ETNB) | 0.2 | $12M | 3.7M | 3.22 | |
| Kezar Life Sciences | 0.2 | $12M | 1.4M | 8.27 | |
| Milestone Pharmaceuticals (MIST) | 0.2 | $11M | 1.8M | 6.15 | |
| Mereo Biopharma Group Ads (Principal) (MREO) | 0.2 | $11M | 9.7M | 1.12 | |
| Danaher Corporation 5% Conv Pfd B (Principal) | 0.2 | $11M | 8.0k | 1323.17 | |
| Gemini Therapeutics | 0.2 | $9.8M | 5.8M | 1.69 | |
| Chemomab Therapeutics Sponsored Ads | 0.2 | $9.5M | 2.6M | 3.70 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $9.4M | 3.8M | 2.48 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $9.4M | 2.1M | 4.48 | |
| Erasca (ERAS) | 0.2 | $9.3M | 1.7M | 5.57 | |
| Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.2 | $9.0M | 20M | 0.45 | |
| Jounce Therapeutics | 0.2 | $8.9M | 2.9M | 3.03 | |
| Cullinan Oncology (CGEM) | 0.2 | $8.6M | 671k | 12.82 | |
| Spdr Ser Tr S&p Biotech (XBI) | 0.2 | $8.3M | 112k | 74.27 | |
| Fusion Pharmaceuticals | 0.1 | $8.0M | 3.2M | 2.49 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $7.5M | 479k | 15.63 | |
| Galecto | 0.1 | $7.1M | 4.1M | 1.73 | |
| Synlogic | 0.1 | $6.9M | 6.0M | 1.15 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $6.9M | 6.9M | 0.99 | |
| Pulmonx Corp (LUNG) | 0.1 | $6.4M | 435k | 14.72 | |
| Scholar Rock Hldg Corp (SRRK) | 0.1 | $5.9M | 1.1M | 5.49 | |
| Cybin Ord | 0.1 | $5.9M | 11M | 0.56 | |
| Harpoon Therapeutics | 0.1 | $5.8M | 3.0M | 1.91 | |
| Mirum Pharmaceuticals (MIRM) | 0.1 | $5.4M | 280k | 19.46 | |
| Imara | 0.1 | $5.4M | 4.4M | 1.22 | |
| Immunocore Hldgs Ads (IMCR) | 0.1 | $4.9M | 131k | 37.31 | |
| Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.1 | $4.9M | 6.0M | 0.81 | |
| Graybug Vision Com Shs | 0.1 | $4.5M | 4.2M | 1.09 | |
| Vor Biopharma (VOR) | 0.1 | $4.1M | 833k | 4.97 | |
| Burning Rock Biotech Sponsored Ads | 0.1 | $4.0M | 1.4M | 2.91 | |
| Applied Therapeutics (APLT) | 0.1 | $4.0M | 4.3M | 0.95 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $4.0M | 1.6M | 2.52 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $3.9M | 2.1M | 1.83 | |
| Novavax Com New Call Option (NVAX) | 0.1 | $3.9M | 75k | 51.43 | |
| Celldex Therapeutics Com New (CLDX) | 0.1 | $3.0M | 113k | 26.96 | |
| Logicbio Therapeutics | 0.1 | $3.0M | 8.5M | 0.35 | |
| Acutus Medical (AFIB) | 0.1 | $3.0M | 2.6M | 1.12 | |
| Magenta Therapeutics | 0.0 | $2.7M | 2.3M | 1.20 | |
| Oncocyte | 0.0 | $2.6M | 2.8M | 0.90 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $2.4M | 831k | 2.93 | |
| Graphite Bio | 0.0 | $2.3M | 848k | 2.75 | |
| 9 Meters Biopharma | 0.0 | $2.2M | 8.5M | 0.26 | |
| Singular Genomics Systems In | 0.0 | $2.1M | 541k | 3.82 | |
| Chardan Healthcare Acqu- Ord | 0.0 | $2.1M | 2.8M | 0.73 | |
| Kalvista Pharmaceuticals (KALV) | 0.0 | $1.8M | 185k | 9.84 | |
| Sight Sciences (SGHT) | 0.0 | $1.8M | 200k | 8.99 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.0 | $1.7M | 214k | 7.87 | |
| Sarepta Therapeutics (SRPT) | 0.0 | $1.5M | 20k | 74.95 | |
| X4 Pharmaceuticals | 0.0 | $1.3M | 1.4M | 0.97 | |
| Sonendo (SONX) | 0.0 | $1.2M | 724k | 1.72 | |
| Talaris Therapeutics | 0.0 | $1.1M | 236k | 4.51 | |
| Vigil Neuroscience (VIGL) | 0.0 | $1.1M | 411k | 2.58 | |
| Aeglea Biotherapeutics | 0.0 | $908k | 1.8M | 0.51 | |
| Longboard Pharmaceuticals In | 0.0 | $351k | 114k | 3.09 | |
| Aptinyx | 0.0 | $300k | 539k | 0.56 |
